A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC
A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC
Not yet recruiting · NCT07086326 · Registry updated 2025-07-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC | non-small cell lung carcinoma | Not yet recruiting | Phase 2 | 2025-07-25 | NCT07086326 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yang Fan, MD | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hunan Cancer Hospital | Changsha | China | 87 |
| Peking University People's Hospital | Beijing | China | 12 |
| Second Affiliated Hospital, School of Medicine, Zhejiang University | Hangzhou | China | 17 |
| Shanghai Chest Hospital | Shanghai | China | 31 |
| The First Affiliated Hospital of Xi'an Jiaotong University | Xi’an | China | 22 |